Cost and Quality

"Cost and Quality" Main

Latest Morning Briefing Stories

DeVos Applauds Efforts To Keep Arizona Schools Open

KHN Morning Briefing

Arizona Gov. Doug Ducey, who toured with Education Secretary Betsy DeVos, said families deserve options for learning despite an uptick in cases. More school news is from New York, the District of Columbia, Massachusetts, Indiana and elsewhere.

Now It’s Republicans Rejecting A White House-Backed Relief Deal

KHN Morning Briefing

Up to now, the stimulus stalemate has primarily been between House Democrats and White House negotiators. But the latest $1.8 trillion proposed package, which President Donald Trump says he supports, was nixed Thursday by Senate Majority Leader Mitch McConnell.

Striking Back Against Foes, Trump Withholds Millions In Federal Funds

KHN Morning Briefing

The Trump administration rejected California’s request for disaster-relief funds to help it recover from some of the worst wildfires in the state’s history. It also recently withheld health care funds from 9/11 first responders and stimulus checks from incarcerated people, and has threatened to withhold COVID grants from “anarchist” cities.

Biden Campaign’s Approach To Positive COVID Tests Differs To Trump

KHN Morning Briefing

The Biden team revealed some specifics about the first known positive tests among campaign staffers Thursday and stressed the protective measures they are taking. And Democratic vice presidential nominee Kamala Harris halted weekend travel plans “out of an abundance of caution.”

In Major Breakthrough, FDA Approves First Treatment For Ebola

KHN Morning Briefing

With the approval, there are now both a vaccine — Merck’s Ervebo — and a therapeutic to battle Ebola Zaire, one of the deadliest infections known to humankind. The treatment, Inmazeb, is an antibody cocktail made by Regeneron Pharmaceuticals, the same company that is developing a monoclonal antibody treatment for COVID that was given to President Donald Trump this month.

Russia Approves Second COVID Vaccine

KHN Morning Briefing

EpiVacCorona, described as a “peptide-based shot,” has yet to even begin large-scale trials. Russia announced its first vaccine, Sputnik V, on Aug. 11.

Private White House Warnings About Virus’ Threat Inflamed Market Sell-Off

KHN Morning Briefing

The rosy picture the Trump administration painted for the public in the early weeks of the coronavirus outbreak contrasts with the more dire closed-door briefings provided by economists to administration officials and Republican donors and passed along to investors, the New York Times reports. In other administration news: Dr. Deborah Birx’s role in undermining WHO and efforts to halt Nevada from using Chinese-made COVID test kits.

In Letter, Scores Of Scientists Strongly Denounce Herd Immunity

KHN Morning Briefing

The letter is a direct rebuttal to reports this week that Trump administration is pushing the controversial approach. “This is a dangerous fallacy unsupported by scientific evidence,” the letter says. “Uncontrolled transmission in younger people risks significant morbidity and mortality across the whole population.”

Federal Survey Will Help Evaluate Electronic Health Record Systems

KHN Morning Briefing

Clinicians, pharmacists and hospital information technology staff will be asked to answer questions evaluating the EHR systems’ interoperability, usability, privacy and other factors. In other news, a doctor faces trial after reports that he mistreated patients with unnecessary gynecological surgeries.